Loading…
XORTX Therapeutics Inc. is projected to rise to $3.15 by 2027, a +31% move from its current price of $2.40. XRTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.23 | $2.40 | $2.57 | -0.18% |
| May 30 | $2.17 | $2.39 | $2.64 | -0.36% |
| May 31 | $2.12 | $2.39 | $2.69 | -0.54% |
| Jun 1 | $2.07 | $2.38 | $2.74 | -0.71% |
| Jun 2 | $2.03 | $2.38 | $2.78 | -0.89% |
| Jun 3 | $2.00 | $2.37 | $2.82 | -1.07% |
| Jun 4 | $1.97 | $2.37 | $2.85 | -1.25% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.97 | $2.37 | $2.85 | -1.25% |
| Week 2 | $1.80 | $2.34 | $3.04 | -2.48% |
| Week 3 | $1.68 | $2.31 | $3.18 | -3.69% |
| Week 4 | $1.58 | $2.28 | $3.30 | -4.89% |
| Week 5 | $1.49 | $2.25 | $3.41 | -6.08% |
| Week 6 | $1.42 | $2.23 | $3.50 | -7.25% |
| Week 7 | $1.35 | $2.20 | $3.58 | -8.40% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
XORTX Therapeutics Inc. is a healthcare company described as a late-stage clinical pharmaceutical company. It engages in the development and commercialization of therapies to treat hyperuricemia related diseases in Canada.
The company leads a pipeline that includes XRx-026 in Phase III for gout, XRx-008 in Phase II for autosomal dominant polycystic kidney disease, XRx-101 in Phase II for acute kidney injury associated with respiratory virus infection, XRX-225 in preclinical development for type 2 diabetic nephropathy, and VB4-P5 for the treatment and prevention of fibrosis in the kidney. The company is based in Calgary, Canada.
XRTX is currently priced at $2.40 per share, with a market capitalization of $4.15M and a rank of 5320. These figures place the stock among smaller-cap healthcare names with a focused pipeline in renal and metabolic diseases.
A major floor 39.2% below — a decisive break under it would weaken the trend.
The nearest floor, 16.3% below — buyers have tended to step in here.
The nearest ceiling, 26.2% above — a clean break opens room to run.
A major ceiling 45.8% above — clearing it would confirm fresh momentum.
Key XRTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of XRTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.34 | Buy | $2.36 | Buy |
| MA 10 | $2.35 | Buy | $2.39 | Buy |
| MA 20 | $2.54 | Sell | $2.45 | Sell |
| MA 50 | $2.38 | Buy | $2.45 | Sell |
| MA 100 | $2.40 | Buy | $2.55 | Sell |
| MA 200 | $3.01 | Sell | $3.52 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.59 | Neutral |
| Stoch RSI (14) | 62.27 | Neutral |
| CCI (20) | -43.19 | Neutral |
| Williams %R (14) | -50.00 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -13.98 | Sell |
| Bollinger %B (20,2) | 0.36 | Neutral |
| Stochastic %K (14) | 50.00 | Neutral |
| TRIX (15) | -0.04 | Sell |
| Awesome (5,34) | -0.19 | Sell |
| Ultimate (7,14,28) | 41.62 | Neutral |
| Momentum (10) | -0.03 | Sell |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 2.28 | Buy |
| ADX (14) | 10.29 | Neutral |
| ATR (14) | 0.16 | Info |
The near-term technical picture is neutral. RSI14 is 50 and the stock sits between the 50-day moving average of $2.38 and the 200-day moving average of $3.01. The current technical setup shows crucial support at $2.01 and resistance at $3.03.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.73 | $2.40 | $3.38 | 0% | Neutral | |
| $2.27 | $3.15 | $4.73 | +31% | Bullish | |
| $2.38 | $3.51 | $5.61 | +46% | Bullish | |
| $2.29 | $3.56 | $5.97 | +48% | Bullish | |
| $2.17 | $3.52 | $6.14 | +47% | Bullish | |
| $1.64 | $2.79 | $5.04 | +16% | Neutral | |
| $1.65 | $2.93 | $5.44 | +22% | Bullish | |
| $2.13 | $3.93 | $7.51 | +64% | Bullish | |
| $2.36 | $4.53 | $8.87 | +89% | Bullish | |
| $2.52 | $5.02 | $10.05 | +109% | Bullish | |
| $2.58 | $5.74 | $12.62 | +139% | Bullish | |
| $3.83 | $8.52 | $19.60 | +255% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.73 | $2.40 | $2.84 | +0.00% |
| June 2026 | $1.81 | $2.17 | $2.69 | -9.77% |
| July 2026 | $1.67 | $2.04 | $2.60 | -5.87% |
| August 2026 | $1.79 | $2.22 | $2.88 | +8.73% |
| September 2026 | $1.82 | $2.28 | $3.01 | +2.77% |
| October 2026 | $1.71 | $2.16 | $2.90 | -4.99% |
| November 2026 | $1.78 | $2.27 | $3.07 | +4.76% |
| December 2026 | $1.92 | $2.47 | $3.38 | +8.85% |
Click any year to see its month-by-month XRTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The XRTX price prediction for 2026 points to an average of $2.40 (low $1.73, high $3.38) — a potential gain of 0% on today's $2.40. A consolidation phase looks the most probable path here.
In 2027, XRTX is projected to trade between $2.27 and $4.73, averaging $3.15 — a potential gain of +31% from today's $2.40. That is up +31% on the projected 2026 average. Momentum favours further upside here.
XORTX Therapeutics Inc.'s 2028 outlook centres on $3.51, within a $2.38 to $5.61 range. That is up +12% on the projected 2027 average. That marks a +46% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, XRTX could reach as high as $5.97, with a base case around $3.56 and support toward $2.29 — roughly +48% from $2.40. Momentum favours further upside here.
Expect XRTX to range from $2.17 to $6.14 through 2030. The $3.52 average target implies a +47% move from current prices. That is -1% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
The XRTX price prediction for 2031 points to an average of $2.79 (low $1.64, high $5.04) — a potential gain of +16% on today's $2.40. Price action looks broadly range-bound.
In 2032, XRTX is projected to trade between $1.65 and $5.44, averaging $2.93 — a potential gain of +22% from today's $2.40. That is up +5% on the projected 2031 average. Buyers look set to stay in control over this stretch.
XORTX Therapeutics Inc.'s 2033 outlook centres on $3.93, within a $2.13 to $7.51 range. That is up +34% on the projected 2032 average. That marks a +64% change versus current levels. Momentum favours further upside here.
By 2034, XRTX could reach as high as $8.87, with a base case around $4.53 and support toward $2.36 — roughly +89% from $2.40. Buyers look set to stay in control over this stretch.
Expect XRTX to range from $2.52 to $10.05 through 2035. The $5.02 average target implies a +109% move from current prices. That is up +11% on the projected 2034 average. Momentum favours further upside here.
The XRTX price prediction for 2040 points to an average of $5.74 (low $2.58, high $12.62) — a potential gain of +139% on today's $2.40. Buyers look set to stay in control over this stretch.
In 2050, XRTX is projected to trade between $3.83 and $19.60, averaging $8.52 — a potential gain of +255% from today's $2.40. That is up +49% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in XRTX today (≈ 416.666667 XRTX) could be worth
$3,549.99
+$2,549.99 (+255%) by 2050 · US Dollar
Based on the average projected XRTX price of $8.52 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in XRTXwould be worth at today's price.
$1,000 invested in XRTX on May 27, 2025 (≈ 217.155265 XRTX) would be worth
$521.17
-$478.83 (-47.9%) today · 0.52× · US Dollar
Based on a XRTX entry price of $4.61 vs. today's $2.4.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.43 | $987.65 | -1.2% |
| 1 month ago | $2.97 | $808.08 | -19.2% |
| 3 months ago | $2.02 | $1,188.12 | +18.8% |
| 6 months ago | $3.24 | $740.74 | -25.9% |
| 1 year ago | $4.61 | $521.17 | -47.9% |
| All time (4.7y) ago | $2,030.27 | $1.18 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our XRTX forecast.
Our base-case forecast reaches $4.80 around 2035.
Implied market cap at $4.80: $8.31M
The multi-year forecast portrays a generally rising price trajectory with a bullish tilt in several later years. For 2026, the min, avg, and max are $1.73, $2.40, and $3.38, respectively (sentiment NEUTRAL, ROI 0). From 2027 onward, the avg price climbs to $3.15 (2027), then to $3.51 (2028) and $3.56 (2029), with ROI values of 31.1, 46.4, and 48.4 respectively.
By 2030, the avg is $3.52 and the max reaches $6.14 (ROI 46.9). The forecast continues with 2031 at $2.79, 2032 at $2.93, 2033 at $3.93, 2034 at $4.53, and 2035 at $5.02, all with bullish sentiment in most years. Long-run projections extend to 2040 (avg $5.74, max $12.62, ROI 139) and 2050 (avg $8.52, max $19.60, min $3.83, ROI 255), with a sustained bullish tone overall, albeit with the expected uncertainty of future performance.
Tap a question to reveal the answer.
2030 forecast: min $2.17, avg $3.52, max $6.14, ROI 46.9, sentiment BULLISH.
The forecast shows bullish sentiment in multiple years (e.g., 2027-2030, 2033-2035, 2040, 2050) with rising averages and positive ROI (e.g., ROI 31.1 in 2027, ROI 255 in 2050). There is a neutral reading for 2026 and some smaller ROIs in early years, so these are estimates, not guarantees.
Yes. The 2035 maximum is $10.05, with higher ceilings in later years (2040 max $12.62 and 2050 max $19.60).
Current price is $2.40 and market cap is $4.15M.
The 30-day picture shows NEUTRAL sentiment, RSI 14 at 50, SMA50 at $2.38, SMA200 at $3.01, with support at $2.01 and resistance at $3.03. The 30-day range is $1.51 to $3.80, and annualized volatility is 100.
XORTX Therapeutics Inc. Community Discussion
0Share your XORTX Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.